Stay Connected
Join us on Facebook Follow us on Twitter Follow us on linked in Follow us on YouTube
Therapeutic Specialization

Expertise and Experience to
Streamline and Accelerate your Clinical Trials

Medpace is your trusted advisor for the entire clinical development process. We deliver strategic therapeutic leadership from planning through every phase of your project. Medpace expertise and focus brings three key advantages to our Sponsors: 

  • In-depth therapeutic knowledge: Led by some of the industry’s most distinguished medical experts/scientists, Medpace brings valuable insights and knowledge to your research-based drug development. This expertise can significantly speed your pathways to commercialization.
  • Extensive Phase I-IV experience across therapeutic specialties: With Phase I-IV experience in multiple therapeutic specialties around the globe, Medpace is able to leverage our therapeutic experience to provide greater efficiencies, and better designed and executed studies.
  • Global regulatory leadership: Medpace regulatory experts − former government officials with valuable insight to the specific areas of drug approval – work to ensure that every phase of trial is correctly focused and designed for regulatory approval.

Areas of Therapeutic Expertise

 By focusing in select therapeutic fields, Medpace is able to collaborate more effectively with all stakeholders and ultimately accelerate your drug towards approval. Our growing list of therapeutic specialties includes:
  • Cardiology: Medpace has vast experience in both drug and device cardiovascular trials, as well as the conduct of large cardiovascular endpoint trials.
  • Central Nervous System: Drugs for neurologic disorders are increasingly critical for the well-being of the world. Medpace is a leader in helping Sponsors speed the commercialization of new therapies.
  • Infectious Disease and Vaccines: Responding to the global demand for anti-infectives, Medpace has compiled a team of therapeutic and regulatory experts to assist in streamlining drug approval.
  • Endocrine - Metabolic Disorders: Medpace has extensive experience in trial design, drug classes, and disease endpoints for Phase I-IV research in this area. Medpace's experience in conducting diabetes trials around the world is unmatched by any other Clinical Research Organization (CRO).
  • Nephrology: Medpace understands the full spectrum of renal disease and has access to these difficult-to-find patients.
  • Oncology: Medpace responds to the urgent need to develop new oncologic therapies with a dedicated team of oncology specialists who understand the unique complexities of oncology trials.
  • Regenerative Medicine Regenerative Medicine holds the bold promise of discovering new therapeutic approaches to combat diseases that are still out of reach of traditional drugs and biologicals.
Events

May 18 - 21, 2013
Digestive Disease Week
Orlando, US

May 20 - 22, 2013
Global Clinical Trials Outsourcing Summit
Seoul, Korea

May 22 - 23, 2013
Partnerships in Clinical Trials Russia
Istanbul, Turkey

May 23 - 24, 2013
The Neurotech Investing & Partnering Conference 2013
St. Regis San Francisco, US

May 28 - 31, 2013
New Clinical Drug Evalutation Unit Annual Meeting (NCDEU)
Hollywood, US

May 29 - 30, 2013
New York Biotechnology Association (NYBA) Annual Meeting
New York City, US

May 31 - June 4, 2013
American Society of Clinical Oncology (ASCO) Annual Meeting
Chicago, US

June 2 - 5, 2013
81st Congress of the European Atherosclerosis Society
Lyon, France

June 12 - 13, 2013
Outsourcing in Clinical Trials: Medical Devices & Diagnostics
St. Paul, US

June 12 - 13, 2013
Anglonordic Medtech Conference II and Anglonordic Biotech Conference X
London, UK

June 21 - 25, 2013
American Diabetes Association's 73rd Scientific Sessions
Chicago, US

June 23 - 27, 2013
DIA Annual Meeting
Boston, US

July 17 - 18, 2013
Clinical Operations in Oncology Trials USA
Boston, US



REQUEST A MEETING

request info Medpace is ready to help you with your next clinical trial project. Find out more about how we can help.

GO NOW more
Videos



Podcasts/webcasts
US Medical Device Regulations and Regulatory Landscape Mike Winegar
Vice President Regulatory Affairs, Medpace Medical Device

MORE more

QT Evaluation in Early Clinical Development Thomas Todaro, MD, JD, FACC
Medpace Vice President, Medical Affairs

MORE moreGO TO ALL PODCASTS/WEBCASTS